Thrombolytic Treatment Before Stenting Linked to Increased Mortality
15th Feb 2006, 04:09 GMT
DALLAS - The use of thrombolytics before angioplasty or stenting offers no benefit and appears to increase the risk of heart attacks, strokes, or death.
Thrombolytic Treatment Before Stenting Linked to Increased Mortality related news:
- Metabolic acidosis associated with an increased mortality rate — EurekAlert! - Breaking News
- Asthma Treatment Gulf Widening Between Black And White Children — MedPage Today Allergy & Immunology
- Metabolic Acidosis Predicts Mortality In ICU Patients — MedPage Today.com Latest Headlines
- Pivotal Study Published in British Medical Journal Reports: ARIXTRA Was Effective and Well Tolerated in Acutely Ill Medical Patients - Treatment Reduced Risk of Venous ThromboEmbolism — StratWire - Business of Healthcare NewsFeed
- Natriuretic Peptide Is Strong Predictor of Mortality — MedPage Today Cardiovascular
- Viewpoint: Reductions in Hispanic and non-Hispanic Asthma Mortality — Medscape Headlines
- Blood Test Predicts Mortality Risk in Coronary Disease — MedPage Today Cardiovascular
- Study: US Hospitals Rated In Top 5 Percent Have Mortality Rates 27 Percent Lower — Medical News Today RSS/XML Feed
- Small molecules overcome drug resistance in cancers associated with high-risk viruses — KeralaNext: Latest News
- State says 2004 infant mortality rate lowest on record — WOODTV - News - Local
Latest news from MedPage Today Cardiovascular:
- AHA: Women Receive Less Cardiovascular Secondary Prevention
- AHA: Chest Protectors Have Fatal Flaws in Blocking Cardiac Arrest
- AHA: No Cardiovascular Benefit from Folic Acid and B Vitamins
- AHA: Attention from Pharmacist Improves Compliance for Older Patients
- AHA: Non-Invasive Office-Based Test Could Increase Appropriate Use of ICDs
- AHA: Human Atrial Natiuretic Peptide May Reduce Reperfusion Injury
- AHA: Blood Test Improves Management of Acute Heart Failure
- AHA: Novel Drug Effective for Hyponatremia in Heart Failure Patients